Atopic Dermatitis: Updates on Pathophysiology and Management

Atopic dermatitis (atopic eczema) is a chronic relapsing and remitting inflammatory skin disease affecting one in 10 people in their lifetime. Atopic dermatitis is caused by a complex interaction of immune dysregulation, epidermal gene mutations, and environmental factors that disrupts the epidermis causing intensely pruritic skin lesions. Repeated scratching triggers a self-perpetuating itch-scratch cycle, which can have a significant impact on the patient's quality of life. The American Academy of Dermatology has created simple diagnostic criteria based on symptoms and physical examination findings. Maintenance therapy consists of liberal use of emollients and daily bathing with soap-free cleansers. Use of topical corticosteroids is the first-line treatment for atopic dermatitis flare-ups. Pimecrolimus and tacrolimus are topical calcineurin inhibitors that can be used in conjunction with topical corticosteroids as first-line treatment.

    Related Conference of Atopic Dermatitis: Updates on Pathophysiology and Management

    November 05-05, 2024

    7th World Cosmetic and Dermatology Congress

    Paris, France
    April 10-11, 2025

    27th World Dermatology and Aesthetic Congress

    Dubai, UAE
    May 20-21, 2025

    30th International Conference on Dermatology & Skin Care

    Zurich, Switzerland
    July 28-29, 2025

    25th European Dermatology Congress

    Paris, France
    August 20-21, 2025

    26th World Dermatology Congress

    Aix-en-Provence, France

    Atopic Dermatitis: Updates on Pathophysiology and Management Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in